FDA Advisory Panel Says Painkillers Can Stay on Market

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/4505761/4505762" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

After three days of hearings, an FDA advisory panel says that painkillers such as Celebrex and Vioxx need not be removed from the market despite an increased risk of heart attack and stroke. The panel does recommend some restrictions, including lower doses and more customer warnings.



Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.